Vitrolife AB (publ)
VTRLY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,031,339 | $19,038,823 | $24,461,876 | $28,089,868 |
| - Cash | $117,915 | $921,000 | $1,054,000 | $1,135,000 |
| + Debt | $212,863 | $1,993,000 | $1,951,000 | $2,089,000 |
| Enterprise Value | $2,126,288 | $20,110,823 | $25,358,876 | $29,043,868 |
| Revenue | $87,734 | $871,000 | $842,000 | $959,000 |
| % Growth | -89.9% | 3.4% | -12.2% | – |
| Gross Profit | $44,760 | $505,000 | $483,000 | $586,000 |
| % Margin | 51% | 58% | 57.4% | 61.1% |
| EBITDA | $26,793 | $137,000 | $150,000 | $271,000 |
| % Margin | 30.5% | 15.7% | 17.8% | 28.3% |
| Net Income | $10,717 | $100,000 | $100,000 | $139,000 |
| % Margin | 12.2% | 11.5% | 11.9% | 14.5% |
| EPS Diluted | 0.079 | 0.74 | 0.74 | 1.02 |
| % Growth | -89.3% | 0% | -27.5% | – |
| Operating Cash Flow | $26,466 | $151,000 | $69,000 | $268,000 |
| Capital Expenditures | -$6,064 | $0 | $0 | $0 |
| Free Cash Flow | $20,402 | $151,000 | $69,000 | $268,000 |